▶주메뉴 바로가기
▶본문 바로가기
SkyLabs and Chong Kun Dang are initiating sales of ring-type heart monitoring device CART-I for the mass market starting December, SkyLabs announced on Nov. 23. Chong Kun Dang has paid SkyLabs 2.5 ...
The US’ International Trade Commission on Nov. 20 once again delayed its final ruling on a trade secret suit between Korean companies Medytox and Daewoong involving a botulinum toxin strain. The I...
Sartorius, a German life sciences company with 170 years of history, announced on Nov. 12 that it will invest $100 million in Korea’s bio cluster of Songdo in Incheon to build a manufacturing facilit...
Biopharmaceutical firm Samsung Biologics unveiled its first research and development center for contract development in the biotechnology hub in southern San Francisco on Thursday. The contract deve...
Enzychem Lifesciences’ COVID-19 treatment candidate EC-18 was granted by the US’ Food and Drug Administration to carry out phase 2 clinical trial on confirmed patients, the company said on August 7. ...
GC Pharma on July 29 sought the Drug Ministry’s approval to carry out a phase 2 clinical trials of its plasma-derived COVID-19 treatment. The company plans to conduct tests of its GC5131A on 60 pat...
SK Group is pushing for another initial public offering of its health care affiliate SK Bioscience, just a month after SK Biopharmaceuticals’ record-breaking stock market entry last month. SK Biosc...
South Korean biopharma giant Celltrion said on July 24 it has launched phase 1 clinical trials of a potential antiviral antibody treatment for COVID-19 patients. The clinical study follows promisi...
Seegene, a Korean diagnostics company acclaimed for having preemptively developed COVID-19 test kits before the pandemic even reached Korea, has since risen to the second rank on the Kosdaq bourse. ...
We know this by many names. Poo, feces, stool, turd, excrement. ... The list can grow endless if imaginative children join in. But scatology is not a matter to be lightly regarded, as “gut feelings...
SK Biopharmaceuticals, a drug company researching and developing novel medicines for central nervous system disorders, is set to make a record-breaking initial public offering. On June 24, the seco...
South Korean drug developer SK Biopharmaceuticals is likely to get an early admission to join the Kospi 200 -- a basket of top 200 blue-chip stocks of the nation’s benchmark index Kospi -- possibly o...
Biologics drug developer Celltrion said Wednesday it will accelerate its insulin pen biosimilar development along with medical device manufacturer Poonglim Pharmatech. Celltrion will begin developi...
Samsung Biologics has bagged two contract manufacturing deals worth 468 billion won ($378 million) combined, according to its regulatory filing on May 22. The total value of the latest deals is equ...
Macrogen, a genomics biotech company, announced Thursday that its AxenTM Covid-19 RT test kit has gained the Drug Ministry’s approval for export. “We are planning to supply our test kit to major co...
BlackRock sells some of Coway stake
Dunamu’s Q1 profit likely to exceed market expectations on surging coin trades
Shinhan Asset to shy away from domestic equities with low ESG scores
Concerns rise as more young Koreans dip their toes into crypto market
[Feature] Korea’s aging society faces burden of rising debts, heavy taxes
Korea’s coal power plants to lose profitability before lifetimes end: study
17 Korean startup founders named Forbes‘ young innovators
Kospi hits fresh high on foreign, institutional buying
April 23, 2021
![[Feature] Korea’s aging society faces burden of rising debts, heavy taxes](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2021/04/22/20210422000212_0.jpg&md=20210422103252)
